Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | ELF3 |
| Upstream (Parents) |
|---|
| (<<) ATP10B → ELF3 |
| (<<) B3GNT3 → ELF3 |
| (<<) BDH1 → ELF3 |
| (<<) DDR1 → ELF3 |
| (<<) FZD4 → ELF3 |
| (<<) ITGB4 → ELF3 |
| (<<) NR3C1 → ELF3 |
| (<<) PRSS3 → ELF3 |
| (<<) SOX9 → ELF3 |
| (<<) TFPI2 → ELF3 |
| (<<) UBE2C → ELF3 |
| Downstream (Children) |
|---|
| ELF3 → ACTN4 (>>) |
| ELF3 → BLNK (>>) |
| ELF3 → CEACAM1 (>>) |
| ELF3 → CREB3L1 (>>) |
| ELF3 → F2RL1 (>>) |
| ELF3 → FAS (>>) |
| ELF3 → FUT2 (>>) |
| ELF3 → FZD7 (>>) |
| ELF3 → GDF15 (>>) |
| ELF3 → GSK3B (>>) |
| ELF3 → IQSEC2 (>>) |
| ELF3 → ITGB6 (>>) |
| ELF3 → JUN (>>) |
| ELF3 → LGALS3 (>>) |
| ELF3 → NBL1 (>>) |
| ELF3 → PIK3C2B (>>) |
| ELF3 → S100A2 (>>) |
| ELF3 → S100P (>>) |
| ELF3 → SLC5A1 (>>) |
| ELF3 → SULT2B1 (>>) |
| ELF3 → SYK (>>) |
| ELF3 → TGFA (>>) |
| ELF3 → TSC22D1 (>>) |
| ELF3 → UGDH (>>) |
| ELF3 → VEGFA (>>) |
